Q32 Bio (QTTB) announced topline results from the SIGNAL-AA Phase 2a signal finding clinical trial evaluating bempikibart, or ADX-914, which identified encouraging clinical activity in patients ...

Cereno's expanded access program for investigational therapy CS1 covers 10 PAH patients, following a Phase 2a clinical trial.

MetaVia (MTVA) announced positive top-line 16-week results from the two-part Phase 2a clinical trial in patients with presumed metabolic dysfunction-associated steatohepatitis, or MASH.

Bioxodes enrolls patients in phase 2a clinical trial of BIOX-101 in intracerebral hemorrhagic stroke: Gosselies, Belgium Saturday, December 21, 2024, 15:00 Hrs [IST] Bioxodes SA, ...

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

Topline data from the chronic cohort is expected in Q2 2025Institutional Review Board (IRB) protocol amendment changes ...

Each of the two parts of the Phase 2a trial of DA-1241 were designed ... For more information on this clinical trial, please visit: www.clinicaltrials.gov NCT06054815. About DA-1241 DA-1241 ...

Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks InflaRx ( (IFRX) ) has issued an update.

Centessa Pharmaceuticals, founded from the merger of 10 biotech companies, is based on an asset-centric model, primarily ...

Along with the potential to achieve improved patient health outcomes, results from the phase 2a trials with TRP-8802 will ...

Each of the two parts of the Phase 2a trial of DA-1241 were designed to be 16-week ... levels at Week 16. For more information on this clinical trial, please visit: www.clinicaltrials.gov NCT06054815.